Antibody-drug conjugates in hematologic malignancies

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages

  Leslie, Lori A ^a   Younes, Anas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ANIMAL; DRUG DESIGN; HEMATOLOGIC NEOPLASMS; HUMAN; IMMUNOLOGY; LEUKEMIA; LYMPHOMA; METABOLISM; MOLECULARLY TARGETED THERAPY; MULTIPLE MYELOMA; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCONJUGATES; LEUKEMIA; LYMPHOMA; MOLECULAR TARGETED THERAPY; MULTIPLE MYELOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84946235907     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.e108     Document Type: Review

References (0)